{
    "nctId": "NCT02557412",
    "officialTitle": "Long-term Effect of Nasal Continuous Positive Airway Pressure on Lipid Profile in Patients With Dyslipidaemia and Mild-moderate Obstructive Sleep Apnea",
    "inclusionCriteria": "* Diagnosis of dyslipidemia: The existence of a previous clinical diagnostic of dyslipidemia associated with lipid-lowering therapy. It is also considered patients who have an altered analytical, using the following cutoffs: total cholesterol \u2265 200 mg / dl, triglycerides \u2265 180 mg / dl, HDL-cholesterol \u2264 40 mg / dl or LDL-cholesterol \u2265 150 mg / dl. Lipid-lowering treatment and diet, stable in the last month.\n* A concentration of LDL-cholesterol above 100 mg / dl, in the month prior to inclusion.\n* An apnea-hypopnea index between 5-30 h-1\n* Must have minimum age of 35 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "* Apnea-hypopnea index of less than 5 h-1 or greater than 30 h-1.\n* Predominance of central apneas and hypopneas, defined as more than 25% of all respiratory events.\n* Professional drivers, risk profession or respiratory failure (according to criteria of the clinical pathway for diagnosis and treatment of sleep-disordered breathing).\n* Very excessive daytime sleepiness (Epworth Sleepiness Scale\\> 18).\n* Morbid obesity (BMI\\> 40 kg / m2).\n* Prior treatment with CPAP."
}